HLS Therapeutics Inc. (TSX:HLS)
Canada · Delayed Price · Currency is CAD 3.920
-0.110 (-2.73%)
Aug 10, 2026, 4:00 PM EST
HLS Therapeutics Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 55.74 | 55.5 | 56.62 | 63.07 | 61.47 | 60.01 |
Revenue Growth | -1.81% | -1.98% | -10.23% | 2.61% | 2.43% | 6.95% |
Gross Profit Gross Profit Growth | 45.38 | 45.42 | 47.62 | 55.45 | 56.49 | 56.04 |
Operating Income Operating Income Growth | -5.3 | -5.48 | -5.29 | -16.57 | -18.68 | -6.45 |
Net Income Net Income Growth | -10.29 | -12.43 | -19.66 | -27.53 | -23.6 | -13.12 |
Earnings Per Share EPS Growth | -0.32 | -0.39 | -0.62 | -0.85 | -0.73 | -0.41 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Canada Canada Growth | 42.7 | 42.47 | 42.65 | 39.29 | 37.02 | 34.69 |
United States United States Growth | 12.49 | 12.56 | 13.19 | 18.47 | 19.56 | 20.17 |
Rest of World Rest of World Growth | 0.55 | 0.48 | 0.79 | 5.31 | 4.88 | 5.15 |
Total Total Growth | 55.74 | 55.5 | 56.62 | 63.07 | 61.47 | 60.01 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 12.33 | 11.72 | 17.46 | 21.95 | 20.72 | 21.18 |
Total Debt Total Debt Growth | 45.55 | 51.5 | 67.26 | 91.11 | 100.05 | 100.35 |
Net Cash (Debt) Net Cash Growth | -33.23 | -39.77 | -49.81 | -69.16 | -79.33 | -79.17 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -1.06 | -1.26 | -1.56 | -2.14 | -2.45 | -2.46 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 19.95 | 17.13 | 8 | 15.79 | 16.94 | 16.43 |
Capital Expenditures CapEx Growth | -0.18 | -0.21 | -0.02 | -0.04 | -0.05 | -0.05 |
Free Cash Flow Free Cash Flow Growth | 19.77 | 16.93 | 7.99 | 15.75 | 16.9 | 16.38 |
Free Cash Flow Growth | 84.18% | 111.88% | -49.28% | -6.80% | 3.14% | 76.00% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 81.40% | 81.83% | 84.11% | 87.91% | 91.90% | 93.38% |
Operating Margin | -9.51% | -9.88% | -9.34% | -26.26% | -30.39% | -10.75% |
Pretax Margin | -19.22% | -23.20% | -27.52% | -44.08% | -38.59% | -19.68% |
Profit Margin | -18.46% | -22.40% | -34.71% | -43.65% | -38.39% | -21.86% |
FCF Margin | 35.47% | 30.50% | 14.11% | 24.97% | 27.49% | 27.30% |
| Fiscal Year | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.076 | 0.148 | 0.158 |
Dividend Per Share Growth | -48.76% | -6.50% | 0.69% |
Dividend Yield | 2.50% | 2.11% | 1.34% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 11, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Forward PE | - | 50.92 | 50.92 | 50.92 | 50.92 | 185.98 |
P/FCF Ratio | 4.44 | 6.49 | 10.90 | 6.05 | 13.87 | 23.51 |
PS Ratio | 1.58 | 1.98 | 1.54 | 1.51 | 3.81 | 6.42 |